Asterias Biotherapeutics - Company & Market Research Reports

Asterias Biotherapeutics focuses on developing and commercializing novel therapies in the fields of cell therapy and regenerative medicine. The company develops therapeutic products in the areas of neurology and oncology. Its best known products are AST-VAC1, AST-VAC2 and AST-OPC1. The company was formerly known as BioTime Acquisition Corporation and changed its name to Asterias Biotherapeutics, Inc. in March 2013. Asterias Biotherapeutics, Inc. was founded in 2012 and is headquartered in Menlo Park, California.

Stem Cell Therapy for Osteoarthritis - A Pipeline Analysis Report - Product Thumbnail Image

Stem Cell Therapy for Osteoarthritis - A Pipeline Analysis Report

  • Report
  • 70 Pages
From
Stem Cell Therapies in Neurology - Product Thumbnail Image

Stem Cell Therapies in Neurology

  • Report
  • 67 Pages
From
Stem Cell Therapy for Multiple Sclerosis - A Pipeline Analysis report - Product Thumbnail Image

Stem Cell Therapy for Multiple Sclerosis - A Pipeline Analysis report

  • Report
  • 72 Pages
From
Strategic Development of Neural Stem & Progenitor Cell Products (2018) - Product Thumbnail Image

Strategic Development of Neural Stem & Progenitor Cell Products (2018)

  • Report
  • 210 Pages
From
Human Embryonic Stem Cell (hESC) Research - Global Strategic Business Report - Product Thumbnail Image

Human Embryonic Stem Cell (hESC) Research - Global Strategic Business Report

  • Report
  • 107 Pages
From
Non-Small Cell Lung Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Non-Small Cell Lung Cancer - Pipeline Review, H1 2018

  • Drug Pipelines
  • 3034 Pages
From
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2018 - Product Thumbnail Image

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2018

  • Drug Pipelines
  • 2103 Pages
From
Dendritic Cell and Tumor Cell Cancer Vaccines Market, 2016-2030 - Product Thumbnail Image

Dendritic Cell and Tumor Cell Cancer Vaccines Market, 2016-2030

  • Report
  • 314 Pages
From
Competitor Analysis: Cancer Vaccines - Product Thumbnail Image

Competitor Analysis: Cancer Vaccines

  • Report
  • 179 Pages
From
Dendritic Cancer Cell Therapy- Pipeline Insights, 2018 - Product Thumbnail Image

Dendritic Cancer Cell Therapy- Pipeline Insights, 2018

  • Drug Pipelines
From
The Market For Cell Therapy Manufacturing - Strategies for Pricing, Cost Control, Reimbursement, Distribution, & More - Product Thumbnail Image

The Market For Cell Therapy Manufacturing - Strategies for Pricing, Cost Control, Reimbursement, Distribution, & More

  • Report
  • 123 Pages
From
Telomerase Reverse Transcriptase (HEST2 or Telomerase Catalytic Subunit or Telomerase Associated Protein 2 or TERT or EC 2.7.7.49) - Pipeline Review, H1 2018 - Product Thumbnail Image

Telomerase Reverse Transcriptase (HEST2 or Telomerase Catalytic Subunit or Telomerase Associated Protein 2 or TERT or EC 2.7.7.49) - Pipeline Review, H1 2018

  • Drug Pipelines
  • 121 Pages
From
Traumatic Spinal Cord Injury Global Clinical Trials Review, H2, 2018 - Product Thumbnail Image

Traumatic Spinal Cord Injury Global Clinical Trials Review, H2, 2018

  • Clinical Trials
  • 66 Pages
From
Spinal Cord Injury Global Clinical Trials Review, H2, 2018 - Product Thumbnail Image

Spinal Cord Injury Global Clinical Trials Review, H2, 2018

  • Clinical Trials
  • 225 Pages
From
Cell Therapy Manufacturing Market (2nd Edition), 2018-2030 - Product Thumbnail Image

Cell Therapy Manufacturing Market (2nd Edition), 2018-2030

  • Report
  • 444 Pages
From
Regenerative Medicine Market Analysis By Product (Therapeutics {Primary Cell-based, Stem Cell-based, Immunotherapies, & Gene Therapies}, Tools, Banks, & Services), By Therapeutic Category, And Segment Forecasts, 2014 - 2025 - Product Thumbnail Image

Regenerative Medicine Market Analysis By Product (Therapeutics {Primary Cell-based, Stem Cell-based, Immunotherapies, & Gene Therapies}, Tools, Banks, & Services), By Therapeutic Category, And Segment Forecasts, 2014 - 2025

  • Report
  • 250 Pages
From
Telomerase Reverse Transcriptase (Telomerase or HEST2 or Telomerase Catalytic Subunit or Telomerase-Associated Protein 2 or EC 2.7.7.49) - Pipeline Review, H1 2016 - Product Thumbnail Image

Telomerase Reverse Transcriptase (Telomerase or HEST2 or Telomerase Catalytic Subunit or Telomerase-Associated Protein 2 or EC 2.7.7.49) - Pipeline Review, H1 2016

  • Drug Pipelines
  • 107 Pages
From
Tissue Engineering: Technologies and Therapeutic Areas - A Global Market Overview - Product Thumbnail Image

Tissue Engineering: Technologies and Therapeutic Areas - A Global Market Overview

  • Report
  • 279 Pages
From
Neuroprotective Agents: Therapeutic Applications and Global Markets - Product Thumbnail Image

Neuroprotective Agents: Therapeutic Applications and Global Markets

  • Report
  • 133 Pages
From
Regenerative Medicine - Global Trends, Estimates and Forecasts, 2013-2019 - Product Thumbnail Image

Regenerative Medicine - Global Trends, Estimates and Forecasts, 2013-2019

  • Report
  • 379 Pages
From
Loading Indicator
adroll